YESAIR DAVID W has a total of 17 patent applications. Its first patent ever was published in 1986. It filed its patents most often in United States, Australia and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and machines are PHARMACEUTISCHE WERKE NORGINE, SHANGHAI LAIYI BIOMEDICAL RES AND DEV CT CO LTD and XIAMEN ENCHENG PHARMACEUTICAL CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | Australia | 2 | |
#3 | Canada | 2 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | WIPO (World Intellectual Property Organization) | 2 | |
#6 | Denmark | 1 | |
#7 | Hong Kong | 1 | |
#8 | Ireland | 1 | |
#9 | Israel | 1 | |
#10 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Machines |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Fermentation | |
#3 | Therapeutic chemical compounds | |
#4 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Yesair David W | 15 |
#2 | Mckee Robert Travis | 2 |
#3 | Shaw Walter A | 2 |
#4 | Burgess Stephen W | 2 |
Publication | Filing date | Title |
---|---|---|
HK1007956A1 | Mixed lipid-bicarbonate colloidal particles for delivering drugs or calories | |
AU8646291A | Mixed lipid-bicarbonate colloidal particles for delivering drugs or calories | |
DK576086D0 | Mixture for releasing orally administerable substances | |
IE860785L | Composition for delivery of orally administered drugs and other substances | |
US4874795A | Composition for delivery of orally administered drugs and other substances |